GlobalData's clinical trial report, "Impetigo Global Clinical Trials Review, H1, 2013" provides data on the Impetigo clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Impetigo. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Impetigo. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
TOC
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Impetigo 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Impetigo 23
Subjects Recruited Over a Period of Time 24
Prominent Sponsors 25
Top Companies Participating in Impetigo Therapeutics Clinical Trials 27
Prominent Drug Comparison 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
GlaxoSmithKline plc 30
Clinical Trial Overview of GlaxoSmithKline plc 30
Lytix Biopharma AS 31
Clinical Trial Overview of Lytix Biopharma AS 31
LEO Pharma A/S 32
Clinical Trial Overview of LEO Pharma A/S 32
NovaBay Pharmaceuticals, Inc. 33
Clinical Trial Overview of NovaBay Pharmaceuticals, Inc. 33
Ferrer Internacional S.A. 34
Clinical Trial Overview of Ferrer Internacional S.A. 34
Foamix Ltd. 35
Clinical Trial Overview of Foamix Ltd. 35
Interdos Pharma bv 36
Clinical Trial Overview of Interdos Pharma bv 36
Ambria Dermatology AB (Inactive) 37
Clinical Trial Overview of Ambria Dermatology AB (Inactive) 37
InfectoPharm Arzneimittel und Consilium GmbH 38
Clinical Trial Overview of InfectoPharm Arzneimittel und Consilium GmbH 38
GlaxoSmithKline Inc. 39
Clinical Trial Overview of GlaxoSmithKline Inc. 39
Galderma S.A. 40
Clinical Trial Overview of Galderma S.A. 40
Stiefel Laboratories, Inc. 41
Clinical Trial Overview of Stiefel Laboratories, Inc. 41
Clinical Trial Overview of Top Universities / Institutes / Hospitals 42
Menzies School of Health Research 42
Clinical Trial Overview of Menzies School of Health Research 42
Royal North Shore Hospital 43
Clinical Trial Overview of Royal North Shore Hospital 43
The University of Texas Health Science Center at Houston 44
Clinical Trial Overview of The University of Texas Health Science Center at Houston 44
Five Key Clinical Profiles 45
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 83
List of Tables
List of Tables
Impetigo Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Impetigo Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Impetigo Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Impetigo Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 10
Impetigo Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Impetigo Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Impetigo Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
Impetigo Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 14
Impetigo Global Clinical Trials Review, H1, 2013 published by GlobalData in March 31, 2013. This report consists of 83 Pages and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
